🔎 Trials Near Me

Akèy › Rabdomiyosakòm › Massachusetts

Etid klinik pou Rabdomiyosakòm nan Massachusetts

4 etid pou Rabdomiyosakòm ap chèche patisipan nan sit nan Massachusetts.

Vil nan Massachusetts

Tèks ofisyèl etid la (Anglè)

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

  • Dana-Farber Cancer Institute, Boston
  • UMass Memorial Medical Center - University Campus, Worcester
Ap rekriteFaz 3
Jiska laj 50 · Tout sèks · Mizajou Aug 25, 2026 · NCT07466316

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

  • Boston Children's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Ap rekriteFaz 1/2
Laj 1 a 30 · Tout sèks · Mizajou Jul 22, 2026 · NCT06721689

VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors

  • Boston Children's Hospital, Boston
Ap rekriteFaz 1/2
6 Months – 30 Years · Tout sèks · Mizajou Jun 2, 2026 · NCT04796012

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

  • Boston Children's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
  • Brigham and Women's Hospital, Boston
Ap rekriteFaz 1/2
Laj 12 a 49 · Tout sèks · Mizajou Feb 19, 2026 · NCT06709495

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.